Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20265 Citations
Cardiogen4 residuesAEDREach bubble = one amino acid. Size = residue mass. Color = chemical class.Cardiogen (AEDR) is a Khavinson tetrapeptide bioregulator targeting cardiac tissue gene expression. Picomolar concentrations stimulated cardiomyocyte proliferation in rat tissue cultures; no human trials exist. Used within multi-organ bioregulator longevity stacks, not as a standalone peptide. Research-only with preclinical evidence from a single lab group.
10mcg · Daily
Summary: Add 0mL BAC water to your 20mg vial. Draw to < 0.1 units on a U-100 syringe for a 10mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 10mg | Daily |
| Moderate | 20mg | Daily |
| Aggressive | 20mg | 2x Daily |
Cardiogen comes in two forms and the protocols are not interchangeable. The Russian Cytogen capsules follow the label: 2 caps, once or twice daily, 30 days. The Western injectable vials (20 mg lyophilized) use subcutaneous injection at 10 to 20 mg per day for 10 to 20 days. For injectable reconstitution: add 2 mL bacteriostatic water to a 20 mg vial. That gives you 10 mg per mL. A 10 mg dose is 1.0 mL, which is 100 units on a U-100 insulin syringe. One vial gives you exactly 2 doses at 10 mg per day, or 1 dose at 20 mg per day. You won't feel anything. That's normal. The proposed mechanism is cardiomyocyte gene expression modulation, not something that produces a perceivable sensation. Absence of subjective effect does not mean the product failed or worked. Verify your vial with a COA showing HPLC purity at or above 98% and mass spectrometry confirming molecular weight around 489.5 Da for AEDR.
Dosing based on Khavinson Institute protocol — 8 published references.View all sources →
Cross-check your Cardiogen reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Cardiogen (AEDR) is a Khavinson tetrapeptide bioregulator targeting cardiac tissue gene expression. Picomolar concentrations stimulated cardiomyocyte proliferation in rat tissue cultures; no human trials exist. Used within multi-organ bioregulator longevity stacks, not as a standalone peptide. Research-only with preclinical evidence from a single lab group.
